A key component of any company is sales. The product or service must be sold in order for the business to continue running their business. Pharmaceutical companies are not immune to this requirement. It is for this reason that they run advertisements online, on the radio, on billboards, and on television. But it is not only individuals with conditions and diseases that they need to expose their product to. Pharmaceutical companies also need to convince doctors that their drugs work and could be beneficial to patients. It is for this reason that pharmaceutical representatives are sent out into the field, to speak with doctors and hospitals, and showcase the newest drug developments.
Tis the season for getting into awkward conversations with people you probably haven't seen since the last holiday gathering. And while it's difficult to predict the array of questions you'll be asked, one you're certain to hear a few times is, "So, what is it that you do again?" Of course, you can just answer pharmaceutical sales management and let that be the end of it. Or, you could use the opportunity to evangelize about that one specific role that has you excited to go to work each day: Sales operations.
The emergence of big data and advancements in technology and data science approaches has dramatically transformed industries like retail, finance, and travel. The Life Sciences industry is no exception. Companies in the Life Sciences industry have a high-volume of unorganized data sets they are not aware of that contains hidden actionable insights. Life sciences industry is the early adopters of new technologies but still, a huge number of enterprises have not been able to decode the insights because of lack of expertise in pharma data analytics and inefficient pharma master data management.
The pharma industry is undergoing a transformation that is largely being driven by innovation. Innovation not just in products, but also in the way business is conducted, resources are mobilized, and the benefits that the end user experiences. Holistic innovation is what Pharma 3.0 is about, says an EY research.
Swapan Kumar Manna | July 19, 2017
Anupam Nandwana | January 5, 2018
Anupam Nandwana | February 8, 2017
Swapan Kumar Manna | December 19, 2017
Avirup Basu | June 7, 2018